Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 47

Tests names and labsConditionsGenes and analytesMethods

Breast ovarian cancer panel

Centogene AG - the Rare Disease Company
Germany
1914
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Fanconi Anemia Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
1918
  • C Sequence analysis of the entire coding region

TruGenome Predisposition Screen (Whole Genome Sequencing)

Illumina Clinical Services Laboratory Illumina
United States
15411578
  • C Sequence analysis of the entire coding region

Cancer NextGen Sequencing (NGS) Panel

PreventionGenetics
United States
4335
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Fanconi Anemia via the BRIP1/FANCJ Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Fanconi Anemia Sequencing Panel

PreventionGenetics
United States
1616
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Chromosomes, DEB Assay for Fanconi Anemia

Quest Diagnostics Nichols Institute Chantilly
United States
1515
  • B Chromosome breakage studies

Chromosome DEB Assay for Fanconi anemia, Prenatal

Quest Diagnostics Nichols Institute Chantilly
United States
1515
  • B Chromosome breakage studies

BRIP1

Institute for Human Genetics University Clinic Freiburg
Germany
21
  • C Sequence analysis of the entire coding region

COLON, BREAST AND OVARIAN CANCER

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
3531
  • C Sequence analysis of the entire coding region

ONCOLOGY, PANEL

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
6680
  • C Sequence analysis of the entire coding region

Fanconi anemia

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1416
  • C Sequence analysis of the entire coding region

Prostate Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ovarian Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Endometrial Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5814
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Focus Cancer Panel - 40 Genes

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5640
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Fanconi anemia J - FANCJ

Genome Diagnostics VU University Medical Center
Netherlands
11
  • E Sequence analysis of select exons
  • T Targeted variant analysis

CarrierMap

Recombine
United States
299297
  • T Targeted variant analysis

Results: 1 to 20 of 47

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.